Association of the aromatase gene (Cyp19) and endometrial cancer - Testing for Hardy-Weinberg disequilibrium in cancer patients.

被引：0
|
作者：
Gu, CC
Mutch, DG
Goodfellow, PJ
机构：
[1] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
468
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [31] CYP19 GENE RESEQUENCING AND GENOTYPE DRUG RESPONSE-PHENOTYPE ASSOCIATION IN BREAST CANCER TREATED WITH NEOADJUVANT AROMATASE INHIBITORS.
    Ellsworth, K. A.
    Wang, L.
    Moon, I.
    Pelleymounter, L. L.
    Eckloff, B. W.
    Martin, Y. N.
    Fridley, B. L.
    Jenkins, G. D.
    Batzler, A.
    Suman, V. J.
    Ravi, S.
    Dixon, J. M.
    Miller, W. R.
    Wieben, E. D.
    Buzdar, A.
    Weinshilboum, R. M.
    Ingle, J. N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S83 - S83
  • [32] Polymorphisms in the CYP19A1 (Aromatase) gene and endometrial cancer risk in Chinese women
    Tao, Meng Hua
    Cai, Qiuyin
    Zhang, Zuo-Feng
    Xu, Wang-Hong
    Kataoka, Nobuhiko
    Wen, Wanqing
    Xiang, Yong-Bing
    Zheng, Wei
    Shu, Xiao Ou
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (05) : 943 - 949
  • [33] Association of TTTA polymorphism in CYP19 gene with endometrial and ovarian cancers risk in Basrah
    Ayyob, Anwar N.
    Al-Badran, Adnan Issa
    Abood, Rafid A.
    GENE REPORTS, 2019, 16
  • [34] DNA-based variation at the aromatase gene (Cyp19) and its role in breast cancer susceptibility.
    SiegelmannDanieli, N
    Zhang, JQ
    McGlynn, KA
    Buetow, KH
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 2004 - 2004
  • [35] Haplotype-tagging analyses of aromatase (CYP19) and risk of breast cancer.
    Olson, Janet E.
    Ma, Cynthia X.
    Pelleymounter, Linda L.
    Schaid, Daniel J.
    Pankratz, V. Shane
    Vierkant, Robert A.
    Fredericksen, Zachary S.
    Sellers, Thomas A.
    Weinshilboum, Richard M.
    CANCER RESEARCH, 2006, 66 (08)
  • [36] No association between a tetranucleotide repeat polymorphism of CYP19 and prostate cancer
    Li, L
    Cicek, MS
    Casey, G
    Witte, JS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (12) : 2280 - 2281
  • [37] The association of the CYP19 and CYP17 polymorphic markers with sporadic breast cancer
    Artamonov, VV
    Lyubchenko, LN
    Shabanov, MA
    Babenko, OV
    Nemtsova, MV
    Zaletaev, DV
    MOLECULAR BIOLOGY, 2003, 37 (06) : 830 - 835
  • [38] The Association of the CYP19 and CYP17 Polymorphic Markers with Sporadic Breast Cancer
    V. V. Artamonov
    L. N. Lyubchenko
    M. A. Shabanov
    O. V. Babenko
    M. V. Nemtsova
    D. V. Zaletaev
    Molecular Biology, 2003, 37 : 830 - 835
  • [39] A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer
    Young I.E.
    Kurian K.M.
    MacKenzie M.A.F.
    Kunkler I.H.
    Cohen B.B.
    Hooper M.L.
    Wyllie A.H.
    Steel C.M.
    British Journal of Cancer, 2000, 82 (7) : 1247 - 1248
  • [40] CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study
    Thyagarajan, B
    Brott, M
    Mink, P
    Folsom, AR
    Anderson, KE
    Oetting, WS
    Gross, M
    CANCER LETTERS, 2004, 207 (02) : 183 - 189
12345